Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AGC Chemicals, a core division of the global AGC Inc. group, provides advanced chemical solutions and contract development and manufacturing services (CDMO) to the life sciences and pharmaceutical industries. The company specializes in the production of high-purity fluorochemicals, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs) through its AGC Pharma Chemicals business. Additionally, through its subsidiary AGC Biologics, the organization offers extensive manufacturing capabilities for biologics, including monoclonal antibodies, recombinant proteins, and cell and gene therapies. With a global footprint spanning Japan, North America, and Europe, AGC supports clients from pre-clinical development through commercial-scale production. Their expertise spans complex fluorine chemistry, advanced microbial fermentation, and mammalian cell culture systems. The company is a critical partner for biopharmaceutical innovators seeking scalable and compliant manufacturing solutions for both small and large molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AGC Chemicals.